INSPIRING study results contribute to the extensive body of evidence for dolutegravir, the leading integrase strand transfer inhibitor, in diverse and hard to treat patient populations ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced interim (Week 24) study results from INSPIRING, a phase IIIb study evaluating the safety and efficacy of dolutegravir in antiretroviral treatment-naive (ART
Marija Krstic Appointed as General Manager for GSK Thailand
—
GSK, a global biopharmaceutical company, has officially named Marija Krstic as the new Gener...
Photo Release: GSK donates one million baht to the Siriraj Foundation for medical supplies to fight against COVID-19
—
GlaxoSmithKline (Thailand) Limited,...